TGF-β is known to induce transdifferentiation and production of collagen and extracellular matrix proteins in hepatic stellate cells, and deletion of the TGF-β receptor in hepatocytes has been shown to alleviate NASH [29]. Here, TGFB1 is linked to metabolic dysfunction-associated steatohepatitis.